Covered recipient · General Payments record
AHMED ALI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$2,296.61
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.41 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $351.97 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 |
| Actelion Pharmaceuticals US, Inc. | $70.55 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $33.21 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885396225 | CMS |
| Actelion Pharmaceuticals US, Inc. | $37.34 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885396227 | CMS |
| Amgen Inc. | $90.97 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940063645 | CMS |
| Amgen Inc. | $88.62 | 02/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940063647 | CMS |
| Amgen Inc. | $76.37 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940063649 | CMS |
| Amgen Inc. | $96.01 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939423275 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 04/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887788197 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 932508939 | CMS |
| Novartis Pharmaceuticals Corporation | $15.89 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893493917 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.